Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PMD-026 shows safety and initial signs of activity in metastatic breast cancer

Dec. 14, 2020

MET no better than EMT for cancer metastases

Dec. 14, 2020

Boryung Pharmaceutical describes new PI3Kdelta and/or DNA-PK inhibitors

Dec. 14, 2020

Hinova Pharmaceuticals patents new PROTACs

Dec. 14, 2020

Novel potent PI3Kdelta inhibitors that target two different mechanisms of isoform selectivity

Dec. 14, 2020

AbbVie conducts phase Ib study of eftozanermin alfa in relapsed or refractory multiple myeloma

Dec. 14, 2020

Ascentage reports clinical data on APG-2575 in CLL

Dec. 11, 2020

Mutant EGFR inhibitors presented by Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical

Dec. 11, 2020

Shanghai Daoshang Biology Tech, Shanghai Medicilon patent MNK1 and MNK2 inhibitors

Dec. 11, 2020

New IDO-1 inhibitors presented by BeiGene

Dec. 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...